241 related articles for article (PubMed ID: 30765844)
1. The epidemiology of hepatitis C virus in Central Asia: Systematic review, meta-analyses, and meta-regression analyses.
Botheju WSP; Zghyer F; Mahmud S; Terlikbayeva A; El-Bassel N; Abu-Raddad LJ
Sci Rep; 2019 Feb; 9(1):2090. PubMed ID: 30765844
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.
Mahmud S; Akbarzadeh V; Abu-Raddad LJ
Sci Rep; 2018 Jan; 8(1):150. PubMed ID: 29317673
[TBL] [Abstract][Full Text] [Related]
3. The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis.
Chemaitelly H; Chaabna K; Abu-Raddad LJ
PLoS One; 2015; 10(8):e0135281. PubMed ID: 26296200
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review.
Davlidova S; Haley-Johnson Z; Nyhan K; Farooq A; Vermund SH; Ali S
Int J Infect Dis; 2021 Mar; 104():510-525. PubMed ID: 33385583
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses.
Fadlalla FA; Mohamoud YA; Mumtaz GR; Abu-Raddad LJ
PLoS One; 2015; 10(3):e0121873. PubMed ID: 25803848
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses.
Al Kanaani Z; Mahmud S; Kouyoumjian SP; Abu-Raddad LJ
R Soc Open Sci; 2018 Apr; 5(4):180257. PubMed ID: 29765698
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence.
Mohamoud YA; Riome S; Abu-Raddad LJ
Int J Infect Dis; 2016 May; 46():116-25. PubMed ID: 26996460
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis.
Chemaitelly H; Mahmud S; Rahmani AM; Abu-Raddad LJ
Int J Infect Dis; 2015 Nov; 40():54-63. PubMed ID: 26417880
[TBL] [Abstract][Full Text] [Related]
9. Post-Soviet Central Asia: a summary of the drug situation.
Zabransky T; Mravcik V; Talu A; Jasaitis E
Int J Drug Policy; 2014 Nov; 25(6):1186-94. PubMed ID: 24954816
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and genotype distribution of hepatitis C virus in Mongolia: Systematic review and meta-analysis.
Chaabna K; Dashzeveg D; Shagdarsuren T; Al-Rifai RH
Int J Infect Dis; 2021 Apr; 105():377-388. PubMed ID: 33601031
[TBL] [Abstract][Full Text] [Related]
11. Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions.
Kouyoumjian SP; Chemaitelly H; Abu-Raddad LJ
Sci Rep; 2018 Jan; 8(1):1661. PubMed ID: 29374178
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions.
Harfouche M; Chemaitelly H; Kouyoumjian SP; Mahmud S; Chaabna K; Al-Kanaani Z; Abu-Raddad LJ
PLoS One; 2017; 12(10):e0187177. PubMed ID: 29088252
[TBL] [Abstract][Full Text] [Related]
13. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
[TBL] [Abstract][Full Text] [Related]
15. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
[TBL] [Abstract][Full Text] [Related]
16. Systematic overview of hepatitis C infection in the Middle East and North Africa.
Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis.
Chaabna K; Kouyoumjian SP; Abu-Raddad LJ
PLoS One; 2016; 11(2):e0149966. PubMed ID: 26900839
[TBL] [Abstract][Full Text] [Related]
18. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.
Morris MD; Shiboski S; Bruneau J; Hahn JA; Hellard M; Prins M; Cox AL; Dore G; Grebely J; Kim AY; Lauer GM; Lloyd A; Rice T; Shoukry N; Maher L; Page K;
Clin Infect Dis; 2017 Apr; 64(7):860-869. PubMed ID: 28362947
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
